• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自正常和异常受精卵母细胞的囊胚滋养外胚层活检中单倍体和三倍体的发生率。

Incidence of haploidy and triploidy in trophectoderm biopsies of blastocysts derived from normally and abnormally fertilized oocytes.

作者信息

Girardi Laura, Patassini Cristina, Miravet Valenciano Jose, Sato Yoshimi, Fagundes Cagnin Natalia, Castellón Jose Antonio, Cogo Francesco, Zambon Paola, Blesa David, Jimenez Almazan Jorge, Akinwole Adedoyin, Coprerski Bruno, Rubio Carmen

机构信息

Igenomix Italy, Reproductive Genetics, Marostica, Italy.

Igenomix Spain Lab S.L.U., Research and Development, Paterna, Spain.

出版信息

J Assist Reprod Genet. 2024 Dec;41(12):3357-3370. doi: 10.1007/s10815-024-03278-4. Epub 2024 Oct 8.

DOI:10.1007/s10815-024-03278-4
PMID:39378000
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707209/
Abstract

PURPOSE

We aimed to identify the correlation between morphological pronuclear (PN) status and the genetically determined ploidy configuration in preimplantation embryos.

METHODS

A retrospective observational study was conducted on 1982 embryos displaying normal fertilization and 380 embryos showing an atypical PN pattern, tested for aneuploidies and ploidy status via preimplantation genetic testing (PGT) between May 2019 and May 2024. Ploidy prediction was performed using a validated targeted-NGS approach and a proprietary bioinformatic pipeline analyzing SNPs B-allele frequency information. Ploidy results were obtained in relation to the morphological PN pattern and further stratified by mode of PN observation, maternal age, and embryo quality parameters.

RESULTS

Abnormal ploidy results in 2PN-derived embryos were 1% (n = 20/1982): 0.8% showed triploidy and 0.2% haploidy. Ploidy results in relation to PN number in atypical fertilization were as follows: 0PN (n = 150/380) associated with 87.3% of diploidy, 8.7% of haploidy, and 4.0% of triploidy; 1PN-derived blastocysts (n = 73/153) were haploid in 47.7% of cases, 6.5% were triploid, and 45.7% diploid; 2.1PN (n = 23/280) and 3PN patterns (n = 54/280) predicted a triploid result in 34.8% and 74.1% of cases, respectively. PN observation with time-lapse increased ploidy status predictivity from 28.3% to 80.4% (p < 0.01) and reduced expected diploid rates to 19.6% (p < 0.01). Diploidy rate was higher for maternal age ≤ 35 years and for morphologically high-grade embryos.

CONCLUSION

Morphological PN check can be improved by incorporating ploidy analysis within the conventional PGT workflow. Euploid 2PN-derived embryos can be further selected removing haploids and triploids, and some atypical PN pattern can be better classified.

摘要

目的

我们旨在确定植入前胚胎中形态学原核(PN)状态与基因测定的倍性构成之间的相关性。

方法

对1982个显示正常受精的胚胎和380个显示非典型PN模式的胚胎进行了一项回顾性观察研究,这些胚胎在2019年5月至2024年5月期间通过植入前基因检测(PGT)检测了非整倍体和倍性状态。使用经过验证的靶向NGS方法和分析单核苷酸多态性B等位基因频率信息的专有生物信息学流程进行倍性预测。根据形态学PN模式获得倍性结果,并进一步按PN观察模式、产妇年龄和胚胎质量参数进行分层。

结果

2PN来源胚胎的异常倍性结果为1%(n = 20/1982):0.8%为三倍体,0.2%为单倍体。非典型受精中与PN数量相关的倍性结果如下:0PN(n = 150/380)中87.3%为二倍体,8.7%为单倍体,4.0%为三倍体;1PN来源的囊胚(n = 73/153)在47.7%的病例中为单倍体,6.5%为三倍体,45.7%为二倍体;2.1PN(n = 23/280)和3PN模式(n = 54/280)分别在34.8%和74.1%的病例中预测为三倍体结果。使用延时观察PN可将倍性状态预测性从28.3%提高到80.4%(p < 0.01),并将预期的二倍体率降低到19.6%(p < 0.01)。产妇年龄≤35岁和形态学上高级别的胚胎的二倍体率更高。

结论

通过在传统PGT工作流程中纳入倍性分析,可以改进形态学PN检查。可以进一步筛选出整倍体2PN来源的胚胎,去除单倍体和三倍体,并且可以更好地分类一些非典型PN模式。

相似文献

1
Incidence of haploidy and triploidy in trophectoderm biopsies of blastocysts derived from normally and abnormally fertilized oocytes.来自正常和异常受精卵母细胞的囊胚滋养外胚层活检中单倍体和三倍体的发生率。
J Assist Reprod Genet. 2024 Dec;41(12):3357-3370. doi: 10.1007/s10815-024-03278-4. Epub 2024 Oct 8.
2
Abnormally fertilized oocytes can result in healthy live births: improved genetic technologies for preimplantation genetic testing can be used to rescue viable embryos in in vitro fertilization cycles.异常受精的卵母细胞可导致健康的活产:用于胚胎植入前基因检测的改进基因技术可用于在体外受精周期中挽救有活力的胚胎。
Fertil Steril. 2017 Dec;108(6):1007-1015.e3. doi: 10.1016/j.fertnstert.2017.08.004. Epub 2017 Sep 15.
3
The clinical impact of oligozoospermia in oocyte donation ICSI cycles using preimplantation genetic test for aneuploidy.在使用植入前非整倍体基因检测的卵母细胞捐赠ICSI周期中,少精子症的临床影响。
Hum Reprod. 2025 May 13. doi: 10.1093/humrep/deaf080.
4
Evaluation of day 5 versus day 6 blastocyst biopsy in preimplantation genetic testing: clinical and neonatal outcomes.着床前基因检测中第5天与第6天囊胚活检的评估:临床及新生儿结局
Front Endocrinol (Lausanne). 2025 Jun 16;16:1544009. doi: 10.3389/fendo.2025.1544009. eCollection 2025.
5
Could blastocysts derived from abnormal fertilized zygotes be used? A systematic review and meta-analysis.源自异常受精合子的囊胚能否被使用?一项系统评价与荟萃分析。
Eur J Obstet Gynecol Reprod Biol. 2025 Jul;311:114033. doi: 10.1016/j.ejogrb.2025.114033. Epub 2025 May 20.
6
Total gonadotropin dose did not affect euploid blastocyst rates: an analysis of more than 19,000 oocytes.总促性腺激素剂量并不影响整倍体囊胚率:对超过 19000 个卵母细胞的分析。
J Assist Reprod Genet. 2024 Sep;41(9):2385-2396. doi: 10.1007/s10815-024-03183-w. Epub 2024 Jul 13.
7
The use of blastocysts developing from nonpronuclear and monopronuclear zygotes can be considered in PGT-SR: a retrospective cohort study.在植入前基因检测-结构重排(PGT-SR)中可考虑使用由非原核和单原核合子发育而来的囊胚:一项回顾性队列研究。
BMC Pregnancy Childbirth. 2025 May 3;25(1):530. doi: 10.1186/s12884-025-07621-0.
8
Limitations of ploidy prediction by time-lapse morphokinetics and artificial-intelligence-based embryo selection algorithms: trisomies fly under the radar.通过延时形态动力学和基于人工智能的胚胎选择算法进行倍性预测的局限性:三体在监测雷达下漏网。
Reprod Biomed Online. 2025 Jul;51(1):104828. doi: 10.1016/j.rbmo.2025.104828. Epub 2025 Jan 15.
9
Decoding embryo development: the effect of clinical variables in morphokinetics and artificial intelligence quality scoring.解码胚胎发育:临床变量对胚胎动力学及人工智能质量评分的影响
Reprod Biomed Online. 2025 Jul;51(1):104866. doi: 10.1016/j.rbmo.2025.104866. Epub 2025 Feb 15.
10
Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection.体外受精或卵胞浆内单精子注射中染色体数目异常(非整倍体)的植入前基因筛查。
Cochrane Database Syst Rev. 2006 Jan 25(1):CD005291. doi: 10.1002/14651858.CD005291.pub2.

引用本文的文献

1
LINE-1 Methylation sustains telomere length in pregnant women: effects on pregnancy failure.LINE-1甲基化维持孕妇的端粒长度:对妊娠失败的影响。
Clin Epigenetics. 2025 Jul 23;17(1):130. doi: 10.1186/s13148-025-01937-6.
2
Could blastocysts derived from abnormal fertilized zygotes be used? A systematic review and meta-analysis.源自异常受精合子的囊胚能否被使用?一项系统评价和荟萃分析。
Eur J Obstet Gynecol Reprod Biol X. 2025 Mar 18;26:100381. doi: 10.1016/j.eurox.2025.100381. eCollection 2025 Jun.
3
The Identification of Molecular Ploidy Status of Abnormal Pronuclear Zygotes Reveals a Significant Number of Euploid Blastocysts Available for Conception.异常原核受精卵分子倍性状态的鉴定揭示了大量可用于受孕的整倍体囊胚。
Biomedicines. 2024 Dec 28;13(1):51. doi: 10.3390/biomedicines13010051.

本文引用的文献

1
Evaluating the developmental potential of 2.1PN-derived embryos and associated chromosomal analysis.评估 2.1PN 来源胚胎的发育潜能及相关染色体分析。
J Assist Reprod Genet. 2024 Jun;41(6):1597-1603. doi: 10.1007/s10815-024-03113-w. Epub 2024 Apr 13.
2
The utility of human two plus one small pronucleated zygotes (2.1PN) based on clinical outcomes and the focused ploidy analysis.基于临床结局和聚焦倍性分析的人类 2PN 期小原核二倍体胚胎的应用。
J Assist Reprod Genet. 2024 Jun;41(6):1589-1596. doi: 10.1007/s10815-024-03114-9. Epub 2024 Apr 13.
3
Developmental competence and neonatal outcomes of nonpronuclear zygotes following single vitrified-warmed blastocyst transfers using propensity score matching analysis.使用倾向性评分匹配分析评估单个玻璃化冷冻解冻囊胚移植后非原核受精卵的发育能力和新生儿结局。
Arch Gynecol Obstet. 2024 Jan;309(1):295-304. doi: 10.1007/s00404-023-07235-x. Epub 2023 Oct 3.
4
Meiotic and mitotic aneuploidies drive arrest of in vitro fertilized human preimplantation embryos.减数分裂和有丝分裂的非整倍性导致体外受精的人类胚胎停滞。
Genome Med. 2023 Oct 2;15(1):77. doi: 10.1186/s13073-023-01231-1.
5
Healthy live birth following embryo transfer of a blastocyst of tetrapronuclear (4PN) origin: a case report.四原核(4PN)来源的囊胚胚胎移植后健康活产:一例报告
Hum Reprod. 2023 Sep 5;38(9):1700-1704. doi: 10.1093/humrep/dead151.
6
Clinical outcomes of frozen-thawed blastocysts from zygotes with no or one pronucleus for in vitro fertilization and intracytoplasmic sperm injection cycles.体外受精和卵胞浆内单精子注射周期中无原核或单原核受精卵的冻融囊胚的临床结局。
Arch Gynecol Obstet. 2023 Sep;308(3):1015-1022. doi: 10.1007/s00404-023-07118-1. Epub 2023 Jun 30.
7
Assessing the clinical viability of micro 3 pronuclei zygotes.评估微 3 原核胚胎的临床可行性。
J Assist Reprod Genet. 2023 Jul;40(7):1765-1772. doi: 10.1007/s10815-023-02830-y. Epub 2023 May 25.
8
What happens to abnormally fertilized embryos? A scoping review.异常受精胚胎会怎样?范围综述。
Reprod Biomed Online. 2023 May;46(5):802-807. doi: 10.1016/j.rbmo.2023.02.005. Epub 2023 Feb 22.
9
Accurate detection and frequency of abnormal ploidy in the human blastocyst.准确检测和分析人类囊胚的异常倍性。
F S Sci. 2023 May;4(2S):27-35. doi: 10.1016/j.xfss.2023.02.003. Epub 2023 Mar 1.
10
Improved clinical utility of preimplantation genetic testing through the integration of ploidy and common pathogenic microdeletions analyses.通过整合倍性和常见致病性微缺失分析提高植入前基因检测的临床实用性。
Hum Reprod. 2023 Apr 3;38(4):762-775. doi: 10.1093/humrep/dead033.